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INTRODUCTION: Advanced tumors of the liver involving the inferior vena cava (IVC) have always been
considered a contraindication to surgery.
PRESENTATIONOFCASE:Wereport a case of a patient,whopreviously underwent right hepatectomy,with
recurrence of colorectal liver metastasis invading the IVC. The patient had a liver resection together with
replacement of the vena cava using a ringed polytetraﬂuoroethylene (PTFE) graft tube. The operationwas
carried out in hepatic vascular exclusion (HVE) without the use of veno-venous bypass. The patient waseywords:
nferior vena cava
iver segment anatomy
epatic resection
iver tumor
healthy and tumor-free at 6 months post-surgery.
DISCUSSION: In patients with hepatic malignancy involving the IVC, extended hepatic resection and
reconstruction of the IVC is often the prerequisite to obtaining a resection margin.
CONCLUSION: Extended hepatic resection with IVC reconstruction for hepatic malignancy may offer a
chance of cure to selected patients who otherwise have poor survival rates.
© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
he CCaccess article under t
. Introduction
Hepatic resection is considered ﬁrst-line therapy for many pri-
ary and metastatic liver tumors.1 Thanks to a more careful
erioperative management, the use of highly accurate pre-
perative imaging and the reﬁnement of surgical techniques,
epatic resection has been applied more extensively and success-
ully. Post-operative mortality has currently been reduced to less
han 5% in almost all groups, whereas 5-year survival after hepatic
esection for colorectal metastases, primary tumors or other types
f non-colorectal metastases has increased from 30 to 50%. In the
ast, patients with large tumors involving the inferior vena cava
IVC) were not considered candidates for surgical resection. How-
ver, these untreated patients had a poor survival rate, less than 12
onths, even when using palliative chemotherapy.2
In recent years, the improvement of surgical techniques with
detailed increase in knowledge of the segmental anatomical
tructure of the liver has permitted liver resections that were until
ecently deemed high-risk surgery. Innovative and aggressive
urgical techniques, principally derived from transplant surgery,
uch as hepatic vascular exclusion (HVE), veno-venous bypass
nd ex vivo hepatic resection, have been reported in dealing with
epatic tumors involving the IVC.3,4 An ideal technique for recon-
truction of the IVC has not yet been described. Graft prosthetics
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and autologous or synthetic patches aremethods extensivelymen-
tioned in the literature for repair of the IVC.5 This paper reports a
case of vena cava and hepatic resection for malignant tumors.
2. Case report
In a woman of 67 years in follow-up at our clinic after right
hepatectomy performed 3 years earlier, for colorectal hepatic
metastasis, a new lesionwas detected in the liver. Two years before
the hepatic resection, the patient had been operated on laparo-
scopically for left colectomy for adenocarcinoma G2, T3, N1, M0
(according to TNM, sixth edition).
Quadriphase contrast-enhancement abdomen and chest com-
puted tomography (CT) showed a hypodense lesion in liver
segment IV, 4 cm in diameter, inﬁltrating the intrahepatic portion
of the inferior vena cava. Prior to surgery the patient underwent
magnetic resonance imaging (MRI) with vascular reconstruction in
order to evaluate the relationshipbetween the tumor, the vena cava
and the hepatic veins in detail.
In addition, the patient underwent a stress echocardiogram so
as to evaluate the heart function in view of a total hepatic vascular
exclusion.
The access laparotomy consisted of a bilateral subcostal inci-
sion on the previous surgical scar. After extensive and laborious
adhesiolysis, since part of the colon and small intestine completely
occupied the right upper quadrant, it was possible to expose
the liver. An intraoperative ultrasound scan (IOUS) conﬁrmed
the preoperative ﬁndings and excluded other metastases in liver
s Ltd. This is an open access article under the CC BY-NC-ND license
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rig. 1. Intraoperative ﬁeld after hepatectomy and the reconstruction of the vena
ava.
egments II–III. The operation began by exposing the inferior vena
ava below the tumor and above the hepatic vein; both parts of
he IVC were surrounded by vessel loops. The liver parenchyma
as divided along the umbilical ﬁssure (on the left side), by
sing bipolar forceps. Central venous pressure was constantly
aintained at or below 5cm of H2O during the parenchymal tran-
ection to minimize the risk of bleeding. During the transection,
on-selective portal clamping (Pringle maneuver) was applied
or 12min. We then proceeded with the placement of a vascular
lamp on the infrahepatic vena cava and the other clamp on the
uprahepatic vena cava (above the hepatic vein), completing the
esection of segment IV associated with the excision of retro-
epatic vena cava (Fig. 1). The caval reconstruction was via the
nterposition of a 20mm ringed-PTFE tube graft, in total vascular
xclusion for about 25min. In the ICU, heparin iv anticoagulation
as started, maintaining an activated partial thromboplastin time
atio (aPTT) of 2.5–3. On the ﬁfth post-operative day, the infusion
f IV heparin was stopped and changed to subcutaneous injection
able 1
eported series of combined liver and IVC resections.a
Author Patients Vascular control IVC
reconstruction
Malde et al.9 35 pt TVE 15
In situ 14
Ex vivo 6
Graft tube 12
Direct repair 23
Nuzzo et al.6 23 pt TVE 12
In situ 4
Other 7
Graft tube 7
Direct repair 16
Hashimoto et al.13 18 pt TVE 1
Other 17
Direct 17
Graft tube 1
Azoulay et al.10 22 pt TVE8
In situ9
Other 4
Graft tube 10
Direct repair 12
Hemming et al.3 22 pt TVE 11
In situ 1
Ex vivo 2
Other techniques 7
Graft tube 14
Direct repair 8
Sarmiento et al.12 19 pt TVE 13
Other techniques 6
Graft tube 18
Direct repair 1
Arii et al.5 11 pt TVE 11 Graft tube 9
Direct repair 2
Miyazaki et al.14 16 pt TVE 8
In situ 3
Side clamp 5
Graft tube 1
Direct repair 15
VE: total vascular exclusion; hypothermic in situ and ex situ. Other techniques include
epair includes IVC repair directly or with patch.
a Series with less than three patients excluded.PEN ACCESS
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of low molecular weight heparin (enoxaparin); at the same time,
we started the administration of antioral platelet drugs.
The postoperative period was characterized by no major sur-
gical complications, although the patient developed right pleural
effusion. Histopathological examination of the specimen indicated
an R0 resection margin. The patient was discharged on the 29th
postoperative day. Six months post-operatively, the patient is in
good health and tumor-free.
3. Discussion
Hepatic resection for liver MTS has been shown to result in bet-
ter prognosis than other treatments. Hepatic resection of tumors
located in the middle of the liver and invading the IVC was consid-
ered until recently an absolute contraindication to surgery.
However, thanks to innovative techniques, these types of liver
resections offer a chance of cure to patientswhountil recentlywere
not considered candidates for any surgical treatment. The beneﬁt
of hepatic resection combinedwith resection and reconstruction of
thevenacava isobvious, since it is anattempt toachieveoncological
radicality, otherwise impossible.6
Recent papers have clariﬁed the safety and advantages of com-
bining excision of the IVC in continuity with hepatic resection for
liver malignancy invading the IVC or hepatic vein.
Several surgical techniques are reported in the literature indeal-
ing with tumors involving the IVC (Table 1). The type of surgical
strategies that can be used depends on the extension of the tumor
along the inferior vena cava.7
When the tumor invades a small portion of the IVC, it is possible
to apply a clamp tangentially; in this case, the IVC can be repaired
primarily with a venorraphy or with a patch in enlargement, pro-
vided that there is no excessive narrowing of the vascular lumen.
Caval stenosis, in fact, causes persistent edema of the lower limbs
and, in severe cases, renal dysfunction.2
In caseswhere tumor invasion isquiteextensive, resectionof the
inferior vena cava requires the interruption of the caval ﬂow. In this
case, two different strategies can be used: when the involvement
of the IVC is below the hepatic veins, then a clamp is placed above
the tumor but below the outlet of the hepatic veins into the IVC
R0 surgical
margin
Complications
Dindo> III
In hospital
mortality
Overall survival
18 pt 14 pt 4 pt 5-years 19.6%
23 pt 9 pt 1 pt 3-years 69%
18 pt – – 5-years 46%
22 pt 14 pt 1 pt 5-yers 38.8%
20 pt 10 pt 2 pt 5-yers 33%
16 pt 8 pt 1 pt 5-years 21%
11 pt 2 pt 1 pt 5-years 25%
16 pt 4 pt 1 pt 5-years 22%
: partial IVC clamping, side clamping. Repair: graft tube (ringed-graft tube), direct
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clamping of the intrahepatic cava) with the advantage of being
ble to maintain the blood ﬂow from the liver to the heart while
ollowing resection and reconstruction of the IVC.8
When the clamp is placed on the cava above the hepatic veins,
hen total vascular exclusion (HVE) must be used. The latter can be
erformed with or without veno-venous bypass, depending on the
emodynamic stability of the patient. In this case, it is advisable to
erform the vascular exclusion test in order to check the stability
f the circulation and heart function; however, bypass is recom-
ended in those patientswith heart disease or kidney failure. It has
een suggested, in cases of total vascular exclusion, to begin tomin-
mize warm ischemia of the liver before the caval resection. In our
ase, a total vascular exclusion was achieved as not enough room
as available to place the clamp below the outlet of the hepatic
ein, since the tumor was close to the hepato-caval junction.
Normally, the liver can tolerate total ischemia for 60–90min.9
owever, it is preferable to reduce this time to 60min in cases
f diseased liver. In fact, despite undergoing ischemia for 25min
HVE) plus 12 during the Pringle maneuver, our patient did not
how any signs of postoperative liver failure.
In situ and ex situ (bench surgery) hepatic resection is a partic-
larly demanding surgical alternative, applicable in those cases in
hich the resection of the IVC is also associated with the recon-
truction of the hepatic veins.4
In the literature, many varied surgical options are described in
he reconstruction of the IVC, when this cannot be repaired pri-
arily. Autologous veins have been used with success; however,
rosthetic materials are feasible and produce a long patency. An
8–20mm Goretx® or Dacron® graft appears superior in terms of
atency of that resistance, and this prosthesis is, therefore, the one
ost frequently used in different surgical settings to reconstruct
the cava. The most serious problems that may arise with the use of
the prosthesis are infection and thrombosis.10
The risk of infection after liver resection is a well-documented
problem, which varies between 8 and 28%, thus some authors have
recommended the use of an omental wrap to protect the caval
prosthesis.
Patency of the caval graft is 70% at 5 years, and systemic hep-
arinization started postoperatively, with subsequent conversion to
oral warfarin sodium, is therefore highly recommended. Alterna-
tively, oral platelet inhibitorsmay be used if oral anticoagulants are
contraindicated.
Little has been published on the outcome of primary and
metastatic liver tumors involving the inferior vena cava, as this
surgery is still considered too complex and high risk for mortal-
ity andmorbidity. In themost important cohorts that appear in the
literature, themortality rate is between 9 and 30%. Despite the high
risk faced by patients with this tumor, this high-risk surgery offers
the only chance of curing tumors that would otherwise be con-
sidered non-resectable.11 However, it is worth noting that 5-year
overall survival varies between 22 and 30%, an outcome entirely
comparable to the survival of patientsundergoinghepatic resection
for colon-rectal metastasis.
4. Conclusion
At present, patients with large tumors involving both liver and
vena cavamay be candidates for liver resection and replacement of
the vena cava, achieving long-term survival in selected cases. The
surgical techniques used in the resection of these tumors require
specialized centers with surgeons experienced in complex pro-
cesses of hepato-biliary surgery.
Key learning points
• Hepatic resection of tumors invading the IVC was considered until recently an absolute contraindication to surgery.
• Innovative and aggressive surgical techniques, such as hepatic vascular exclusion (HVE), veno-venous bypass and ex
vivo hepatic resection, have been reported in dealing with hepatic tumors involving IVC.
• Patients with large tumors involving both liver and vena cava may be candidates for liver resection and replacement
of the vena cava achieving long-term survival in selected cases.
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